AU2523588A - Mixture of substances for stabilyzing metabolism - Google Patents
Mixture of substances for stabilyzing metabolismInfo
- Publication number
- AU2523588A AU2523588A AU25235/88A AU2523588A AU2523588A AU 2523588 A AU2523588 A AU 2523588A AU 25235/88 A AU25235/88 A AU 25235/88A AU 2523588 A AU2523588 A AU 2523588A AU 2523588 A AU2523588 A AU 2523588A
- Authority
- AU
- Australia
- Prior art keywords
- metabolism
- agent
- blood circulation
- khellin
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
The invention concerns the use of at least one substance, which may be phenylethyl barbituric acid, papaverine, belladonna extract or theobromine, mixed with an agent for promoting peripheral blood circulation, e.g. khellin (5,8-dimethoxy-2-methylfuro-[4',5':6,7]-chromone), khellin derivatives, pentifyline, cinnerizine, xanthinol nicotinate or Extr. Ginkgo bil. or quercetine (3.5.7.3'.4' pentaoxyflavone) and/or an agent for promoting central blood circulation, e.g. erythrol tetranitrate, isosorbide dinitrate, isosorbide mononitrate, nitroglycerin or nitropentaerythrolum for the manufacture of a drug for stabilizing or normalizing the metabolism and/or the immune system in patients with metabolic disorders, such as diabetics, in particular those obliged to take insulin.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT255887 | 1987-10-08 | ||
AT2558/87 | 1987-10-08 | ||
AT478/88 | 1988-02-25 | ||
AT47888 | 1988-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2523588A true AU2523588A (en) | 1989-05-02 |
Family
ID=25592878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25235/88A Abandoned AU2523588A (en) | 1987-10-08 | 1988-10-07 | Mixture of substances for stabilyzing metabolism |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0339054B1 (en) |
AT (1) | ATE108064T1 (en) |
AU (1) | AU2523588A (en) |
DE (1) | DE3850568D1 (en) |
WO (1) | WO1989003213A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU641721B2 (en) * | 1989-12-21 | 1993-09-30 | Novo Nordisk A/S | Insulin preparations containing nicotinic acid or nicotinamide |
DK150591D0 (en) * | 1991-08-26 | 1991-08-26 | Novo Nordisk As | CHEMICAL COMPOUND |
WO2000002455A1 (en) * | 1998-07-09 | 2000-01-20 | Cv Technologies Inc. | Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
DE19928528C2 (en) * | 1999-06-22 | 2002-10-17 | Heinz Kiefer | Medicines (antiarteriosclerotic) for the prevention and relief of symptoms of arterial circulatory disorders based on ginkgobiloba |
US7195783B2 (en) | 1999-07-09 | 2007-03-27 | Fx Life Sciences International Gmbh | Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
US20090162286A1 (en) * | 2004-06-07 | 2009-06-25 | Pfizer Inc. | Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions |
GB0919893D0 (en) * | 2009-11-13 | 2009-12-30 | Biocopea Ltd | Drug composition and its use in therapy |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
CN115770239B (en) * | 2022-12-05 | 2024-01-30 | 南京中医药大学 | Application of furochrome and pharmaceutically acceptable salt in preparation of medicines for treating peripheral neuropathy |
-
1988
- 1988-10-07 WO PCT/AT1988/000079 patent/WO1989003213A1/en active IP Right Grant
- 1988-10-07 EP EP88908106A patent/EP0339054B1/en not_active Expired - Lifetime
- 1988-10-07 AU AU25235/88A patent/AU2523588A/en not_active Abandoned
- 1988-10-07 AT AT88908106T patent/ATE108064T1/en not_active IP Right Cessation
- 1988-10-07 DE DE3850568T patent/DE3850568D1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3850568D1 (en) | 1994-08-11 |
EP0339054B1 (en) | 1994-07-06 |
EP0339054A1 (en) | 1989-11-02 |
WO1989003213A1 (en) | 1989-04-20 |
ATE108064T1 (en) | 1994-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL87149A (en) | 6-Piperazinyl derivatives of purine and its 3- and 9-deaza isosteres, their preparation and pharmaceutical compositions containing them | |
SG48087G (en) | Orally administrable antidiabetic compositions | |
NO842290L (en) | PROCEDURE FOR THE PREPARATION OF PREPARATIONS CONTAINING ORAL ANTIDIABETIC ACTIVE SUBSTANCES | |
AU2523588A (en) | Mixture of substances for stabilyzing metabolism | |
HUP0002373A2 (en) | Glucagon antagonists/inverse agonists | |
Sharma | Rapid response to loxapine in acute schizophrenia. |